Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Local targets link to admitted publications; unresolved targets remain external evidence.
Coronavirus avian infectious bronchitis virus
10.1051/vetres:2006055 · 2007 · External reference
Human coronaviruses: a review of virus-host interactions
2016 · External reference
10.1016/b978-0-12-385885-6.00009-2
10.1016/b978-0-12-385885-6.00009-2 · External reference
10.3390/v2081803
10.3390/v2081803 · External reference
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
10.1016/s0140-6736(03)13967-0 · 2003 · External reference
10.1056/nejmoa1211721
10.1056/nejmoa1211721 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
2020 · External reference
10.3390/v12020244
10.3390/v12020244 · External reference
10.1146/annurev-micro-020518-115759
10.1146/annurev-micro-020518-115759 · External reference
Self-attention based molecule representation for predicting drug-target interaction
2019 · External reference
10.1093/database/bay083
10.1093/database/bay083 · External reference
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
10.1093/nar/gkl999 · 2007 · External reference
10.1038/nbt1228
10.1038/nbt1228 · External reference
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
2020 · External reference
10.1002/jcc.21334
10.1002/jcc.21334 · External reference
10.1186/1758-2946-3-33
10.1186/1758-2946-3-33 · External reference
10.1002/jcc.21256
10.1002/jcc.21256 · External reference
10.1007/s12551-016-0247-1
10.1007/s12551-016-0247-1 · External reference
10.1093/bioinformatics/bty593
10.1093/bioinformatics/bty593 · External reference
SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines
10.1186/s13321-017-0209-z · 2017 · External reference
Toward more realistic drug-target interaction predictions
10.1093/bib/bbu010 · 2015 · External reference
10.1021/ci400709d
10.1021/ci400709d · External reference
10.1038/nbt.1990
10.1038/nbt.1990 · External reference
Unresolved reference
External reference
Lopinavir; a potent drug against coronavirus infection: insight from molecular docking study
10.5812/archcid.13823 · 2017 · External reference
10.1038/nrmicro.2016.81
10.1038/nrmicro.2016.81 · External reference
drugmakers ship therapies to China, seeking to treat coronavirus
2020 · External reference
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
10.1136/thorax.2003.012658 · 2004 · External reference
10.1038/s41422-020-0282-0
10.1038/s41422-020-0282-0 · External reference
In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2020 · External reference
10.1056/nejmoa2001191
10.1056/nejmoa2001191 · External reference
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
10.5582/bst.2020.01030 · 2020 · External reference
10.1038/d41586-020-00444-3
10.1038/d41586-020-00444-3 · External reference
